Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Incompatibility of ifosfamide with benzyl-alcohol-preserved bacteriostatic water for [PMID: 3369469] Laboratory literature summary: Incompatibility of ifosfamide with benzyl-alcohol-preserved bacteriostatic water for parenteral-route administration
Curious: Do you think the future of peptide research will focus more on full-length compounds, targeted fragments, or a combination of both
All products sold by Ascend Peptides UK are intended strictly for laboratory research purposes only
The same old line about too much B12 being harmful (which is complete rubbish) is often used in these letters and if the patient is unaware of the truth about B12 they might quietly comply with the harmful removal of their vital treatment
10 mg Vial Reconstitution BAC water added 2 mL Concentration 5,000 mcg/mL 250 mcg dose volume 0.05 mL = 5 units 500 mcg dose volume 0.10 mL = 10 units Doses per vial at 250 mcg 40 BAC water added 3 mL Concentration 3,333 mcg/mL 250 mcg dose volume 0.075 mL = ~7.5 units 500 mcg dose volume 0.15 mL = 15 units Doses per vial at 250 mcg 40 Units shown are U-100 insulin syringe units (where 100 units = 1.0 mL)
Batch-specific certificates of analysis are published for every compound
